Recent advances in inflammation & allergy drug discovery · 2026
PEPITEM Reduces Annexin V Immunoreactivity in Spinal Cord Tissue from Experimental Autoimmune Encephalomyelitis Mice.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alassiri Mohammed, Zanoom Nisrin A, Alrfaei Bahauddeen M, Abdullah Mashan L
Аннотация
INTRODUCTION: Multiple sclerosis is a chronic autoimmune demyelinating disease of the central nervous system, and experimental autoimmune encephalomyelitis is widely used as a murine model to study its immunopathological features. PEPITEM regulates leukocyte trafficking; however, its effect on apoptosis-associated tissue changes in EAE remains unclear. This study aimed to determine whether prophylactic or therapeutic administration of PEPITEM alters Annexin V immunoreactivity in spinal cord sections from EAE mice.
METHODS: EAE was induced in female C57BL/6 mice using MOG35-55 immunization. Mice received scrambled peptide or PEPITEM using therapeutic or prophylactic regimens. Paraffinembedded lumbar spinal cord sections were analyzed by Annexin V immunofluorescence staining with DAPI nuclear counterstaining.
RESULTS: Both therapeutic and prophylactic PEPITEM-treated EAE groups showed reduced Annexin V immunoreactivity compared with their corresponding scrambled peptide-treated EAE controls. DAPI staining suggested better preservation of nuclear distribution and morphology in PEPITEM-treated groups.
DISCUSSION: These findings complement previous PEPITEM-EAE studies reporting reduced CNS inflammation, leukocyte infiltration, demyelination, and immune-trafficking gene expression. Annexin V immunofluorescence is supportive rather than definitive, and further validation is needed.
CONCLUSION: PEPITEM treatment was associated with reduced Annexin V immunoreactivity in EAE spinal cord sections, suggesting reduced apoptosis-associated tissue injury.
METHODS: EAE was induced in female C57BL/6 mice using MOG35-55 immunization. Mice received scrambled peptide or PEPITEM using therapeutic or prophylactic regimens. Paraffinembedded lumbar spinal cord sections were analyzed by Annexin V immunofluorescence staining with DAPI nuclear counterstaining.
RESULTS: Both therapeutic and prophylactic PEPITEM-treated EAE groups showed reduced Annexin V immunoreactivity compared with their corresponding scrambled peptide-treated EAE controls. DAPI staining suggested better preservation of nuclear distribution and morphology in PEPITEM-treated groups.
DISCUSSION: These findings complement previous PEPITEM-EAE studies reporting reduced CNS inflammation, leukocyte infiltration, demyelination, and immune-trafficking gene expression. Annexin V immunofluorescence is supportive rather than definitive, and further validation is needed.
CONCLUSION: PEPITEM treatment was associated with reduced Annexin V immunoreactivity in EAE spinal cord sections, suggesting reduced apoptosis-associated tissue injury.